On demand

Cooley Rx series

Life Sciences Litigation: Hatch-Waxman, 2023 Year in Review

January 30, 2024
Event details
January 30, 2024
12:00 pm Pacific Standard Time

Event summary

Cooley Rx is a virtual series focused on the life sciences and healthcare sectors. We discuss the top issues and trends in these industries – and provide decision-makers with information they can use to strengthen their organizations.

Life Sciences Litigation: Hatch-Waxman, 2023 Year in Review

Cooley lawyers Geoff Biegler, Betsy Flanagan and Bonnie Fletcher Price gave a recap of Hatch-Waxman litigation in 2023 and a look forward to 2024. In this session, Geoff, Betsy and Bonnie discussed the need-to-know case outcomes, legal developments, and government initiatives from the past year impacting Hatch-Waxman litigants in both the courtroom and the boardroom. This program is designed for in-house lawyers and executives interested in the latest topics and trends in Hatch-Waxman litigation, whether they are new to the field or have decades of experience.

View on demand

For more information, please email Megan Senerchia.

Cooley Rx programming

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.